13F
Tracker
OverviewMarketsWatchlist

D. E. Shaw & Co., Inc.GARPConcentrated trader

CIK: 0001009207 | New York, NY

Q1 2026 vs Q2 2026 ComparisonProfile

Filing History

QuarterForm TypeHoldingsValueFiledSEC
Q2 2026
13F-HR6298$210.2B2026-08-14SEC ↗
Q1 2026
13F-HR5804$166.3B2026-05-15SEC ↗
Q4 2025
13F-HR5839$182.4B2026-02-17SEC ↗
Q3 2025
13F-HR5726$177.2B2025-11-14SEC ↗
Q2 2025
13F-HR5528$141.1B2025-08-14SEC ↗
Q1 2025
13F-HR5466$112.3B2025-05-15SEC ↗
Q4 2024
13F-HR5526$136.3B2025-02-14SEC ↗
Q3 2024
13F-HR5681$116.5B2024-11-14SEC ↗
Q2 2024
13F-HR5631$106.9B2024-08-14SEC ↗
Q1 2024Amended
13F-HR/A5519$116.8B2024-05-15SEC ↗
Q4 2023Amended
13F-HR/A5506$114.4B2024-02-14SEC ↗
Q3 2023
13F-HR5454$95.8B2023-11-14SEC ↗
Q2 2023
13F-HR5463$97.9B2023-08-14SEC ↗
Q1 2023
13F-HR5641$93.4B2023-05-15SEC ↗
Q4 2022
13F-HR6087$90.5B2023-02-14SEC ↗
Q3 2022
13F-HR6258$7.0B2022-11-14SEC ↗
Q2 2022
13F-HR6343$5.7B2022-08-15SEC ↗
Q1 2022
13F-HR6549$6.1B2022-05-16SEC ↗
Q4 2021
13F-HR6413$6.0B2022-02-14SEC ↗
Q3 2021
13F-HR5998$5.9B2021-11-15SEC ↗
Q2 2021
13F-HR5741$6.2B2021-08-16SEC ↗
Q1 2021
13F-HR5015$5.9B2021-05-17SEC ↗
Q4 2020
13F-HR5021$5.9B2021-02-16SEC ↗
Q3 2020
13F-HR4969$6.3B2020-11-16SEC ↗
Q2 2020
13F-HR5189$5.4B2020-08-14SEC ↗
Q1 2020
13F-HR5172$5.0B2020-05-15SEC ↗
Q4 2019
13F-HR5207$6.2B2020-02-14SEC ↗
Q3 2019
13F-HR4995$5.9B2019-11-14SEC ↗
Q2 2019
13F-HR4893$5.6B2019-08-14SEC ↗
Q1 2019
13F-HR4785$3.9B2019-05-15SEC ↗
Q4 2018
13F-HR4933$2.7B2019-02-14SEC ↗
Q3 2018
13F-HR4883$2.9B2018-11-14SEC ↗
Q2 2018
13F-HR4827$2.6B2018-08-14SEC ↗
Q1 2018
13F-HR4541$2.6B2018-05-15SEC ↗
Q4 2017
13F-HR4685$2.0B2018-02-14SEC ↗
Q3 2017
13F-HR4456$2.1B2017-11-14SEC ↗
Q2 2017
13F-HR4283$2.1B2017-08-14SEC ↗
Q1 2017
13F-HR4247$2.1B2017-05-15SEC ↗
Q4 2016
13F-HR4566$1.9B2017-02-14SEC ↗
Q3 2016
13F-HR4548$2.0B2016-11-14SEC ↗
Q2 2016
13F-HR4705$1.7B2016-08-15SEC ↗
Q1 2016
13F-HR4618$2.0B2016-05-16SEC ↗
Q4 2015
13F-HR5052$2.2B2016-02-16SEC ↗
Q3 2015
13F-HR4978$1.9B2015-11-16SEC ↗
Q2 2015
13F-HR5124$1.6B2015-08-14SEC ↗
Q1 2015
13F-HR4824$1.8B2015-05-15SEC ↗
Q4 2014
13F-HR5016$1.7B2015-02-17SEC ↗
Q3 2014
13F-HR5079$1.9B2014-11-14SEC ↗
Q2 2014
13F-HR5176$1.9B2014-08-14SEC ↗
Q1 2014
13F-HR5152$1.6B2014-05-15SEC ↗
Q4 2013
13F-HR5691$1.5B2014-02-14SEC ↗
Q3 2013Amended
13F-HR/A4957$1.4B2013-11-14SEC ↗
Q2 2013
13F-HR4619$1.1B2013-08-14SEC ↗

In the News

All articles
Bloomberg
Quant Pioneer D.E. Shaw Is Tweaking Its Secret Money Machine

D.E. Shaw is adapting its strategy to counter intensifying competition for talent and rising technology costs by moving some of its best investment ideas to an employee-only fund and tightening client terms. With record assets of about $125 billion, strong recent returns, and a collective leadership structure, the firm is also expanding into human-trader-led strategies while maintaining a strict focus on long-term risk management.

  • The flagship Composite fund returned 15.3% and Oculus returned 30% through September 2026, with total assets reaching a record of about $125 billion.
  • Starting in January, the firm will launch an employee-only fund seeded half by the Composite fund, with staff and partner money already totaling more than $15 billion.
  • Client terms are tightening: lockups are extending to up to four years, and a 0.12% technology surcharge is being added on top of a 0.23% expense fee, alongside its existing 3% management and 35% incentive fees.
  • D.E. Shaw raised about $6 billion for Cogence, its first fund led by human traders, and marketed it to wealthy individuals, breaking with its prior approach.
  • The seven-member executive committee emphasizes collective decision-making and avoids highly leveraged trades, though a consultant downgraded its management rating to above average in 2024.
Summary written by us; may require a subscription to read the original.